These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8852629)

  • 21. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog.
    Clark KL; Robertson MJ; Drew GM
    Br J Pharmacol; 1993 May; 109(1):148-56. PubMed ID: 8495237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-peptide angiotensin II receptor antagonists. 2. Design, synthesis, and biological activity of N-substituted (phenylamino)phenylacetic acids and acyl sulfonamides.
    Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Patchett AA; Greenlee WJ
    J Med Chem; 1993 Dec; 36(26):4239-49. PubMed ID: 8277506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.
    Delisée C; Schaeffer P; Cazaubon C; Chatelain P
    Eur J Pharmacol; 1993 Oct; 247(2):139-44. PubMed ID: 8282003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the AT1 angiotensin II receptor expressed in guinea pig liver.
    García-Sáinz JA; Martínez-Alfaro M; Romero-Avila MT; González-Espinosa C
    J Endocrinol; 1997 Jul; 154(1):133-8. PubMed ID: 9246947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants.
    Vianello B; Clauser E; Corvol P; Monnot C
    Eur J Pharmacol; 1998 Apr; 347(1):113-8. PubMed ID: 9650856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.
    Syvänen S; Eriksson J; Genchel T; Lindhe O; Antoni G; Långström B
    BMC Med Imaging; 2007 Jul; 7():6. PubMed ID: 17663770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of valsartan to mammalian angiotensin AT1 receptors.
    de Gasparo M; Whitebread S
    Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the binding of [125I]L-735,286: a new nonpeptide angiotensin II AT1 receptor radioligand.
    Chen TB; Brenner NJ; Gibson RE; Burns HD; Chang RS
    Life Sci; 1995; 56(8):629-35. PubMed ID: 7869841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
    Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
    Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AT1 receptor characteristics of angiotensin analogue binding in human synovium.
    Walsh DA; Suzuki T; Knock GA; Blake DR; Polak JM; Wharton J
    Br J Pharmacol; 1994 Jun; 112(2):435-42. PubMed ID: 8075862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
    Chang RS; Lotti VJ
    Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the binding of [3H]L-158,809: a new potent and selective nonpeptide angiotensin II receptor (AT1) antagonist radioligand.
    Chen TB; Lotti VJ; Chang RS
    Mol Pharmacol; 1992 Dec; 42(6):1077-82. PubMed ID: 1480133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological reactivity of angiotensin II receptor antagonists: possible implications for receptor binding sites.
    Bensoussan M; Mitchell T; Reilly T; Timmermans PB; Verroust PJ; Ronco PM
    Eur J Pharmacol; 1993 Oct; 247(2):169-75. PubMed ID: 8282006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor.
    Bossé R; Servant G; Zhou LM; Boulay G; Guillemette G; Escher E
    Regul Pept; 1993 Mar; 44(2):215-23. PubMed ID: 8469775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by locally produced luminal angiotensin II of proximal tubular sodium reabsorption via an AT1 receptor.
    Hiranyachattada S; Harris PJ
    Br J Pharmacol; 1996 Oct; 119(4):617-8. PubMed ID: 8904632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II, via an action at AT1 receptors, may modulate the behavioural effects of ET-1 in conscious rats.
    D'Amico M; di Filippo C; Berrino L; Rossi F
    Life Sci; 1996; 59(22):PL355-8. PubMed ID: 8950291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of [¹¹C]PBR170, a novel imidazopyridine, for imaging the translocator protein with PET.
    Bourdier T; Henderson D; Fookes CJ; Lam P; Mattner F; Fulham M; Katsifis A
    Appl Radiat Isot; 2014 Aug; 90():46-52. PubMed ID: 24685494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosynthesis of [11C]Lu 29-024: a potential radiotracer for 5HT2 receptors PET studies.
    Amokhtari M; Andersen K; Ibazizene M; Dhilly M; Dauphin F; Barre L
    Nucl Med Biol; 1998 Aug; 25(6):517-22. PubMed ID: 9751417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.